Go Pro
OTCMKTS:BIOQ

Bioqual (BIOQ) Stock Price, News & Analysis

Bioqual logo
$33.00 0.00 (0.00%)
As of 09/25/2026

About Bioqual Stock (OTCMKTS:BIOQ)

Advanced

Key Stats

Today's Range
$33.00
▼
$33.00
50-Day Range
$32.50
▼
$33.00
52-Week Range
$32.50
▼
$43.55
Volume
N/A
Average Volume
55 shs
Market Capitalization
$29.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bioqual, Inc. is a contract research organization that provides preclinical biomedical research services to pharmaceutical, biotechnology and government customers. The company specializes in infectious disease research and uses laboratory and animal models to support the development and evaluation of vaccines, therapeutics and diagnostic products.

Its services have included studies involving HIV, hepatitis, influenza, COVID-19 and other infectious diseases, as well as immunology, pharmacology and toxicology research. Bioqual also provides research support using nonhuman primate and other animal models, along with laboratory testing and related scientific services.

Based in the United States, Bioqual has historically served customers in the pharmaceutical, biotechnology and public-sector research communities. Publicly available information about its current leadership and operations is limited.

AI Generated. May Contain Errors.

Receive BIOQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioqual and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BIOQ Stock News Headlines

BIOQUAL Presents Financial Results for Fiscal Year 2026
Bioqual (OTCMKTS:BIOQ) Releases Earnings Results
My next big call (under $1)
17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of. But the world's largest bank is already building on it. It has a deflationary burn mechanism tied directly to institutional usage.tc pixel
BIOQUAL Presents Financial Results for Fiscal Year 2025
See More Headlines

BIOQ Stock Analysis - Frequently Asked Questions

Bioqual's stock was trading at $38.51 at the start of the year. Since then, BIOQ shares have decreased by 14.3% and is now trading at $33.00.

Bioqual Inc. (OTCMKTS:BIOQ) announced its quarterly earnings data on Monday, September, 21st. The company reported ($2.81) earnings per share (EPS) for the quarter. The business earned $9.27 million during the quarter. Bioqual had a negative trailing twelve-month return on equity of 11.20% and a negative net margin of 9.75%.

Shares of BIOQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioqual investors own include Align Technology (ALGN), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Global X Cloud Computing ETF (CLOU).

Company Calendar

Last Earnings
9/21/2026
Today
9/27/2026
Fiscal Year End
5/31/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:BIOQ
CIK
719711
Fax
N/A
Employees
114
Year Founded
1981

Profitability

EPS (Trailing Twelve Months)
($3.78)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.17 million
Net Margins
-9.75%
Pretax Margin
-9.30%
Return on Equity
-11.20%
Return on Assets
-5.82%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.22
Quick Ratio
4.22

Sales & Book Value

Annual Sales
$39.95 million
Price / Sales
0.74
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$36.23 per share
Price / Book
0.91

Miscellaneous

Outstanding Shares
890,000
Free Float
543,000
Market Cap
$29.37 million
Optionable
Not Optionable
Beta
-0.20

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:BIOQ) was last updated on 9/28/2026 by MarketBeat.com Staff.
From Our Partners